Some investors think the market's been too hard on these drugmakers.
News & Analysis: Urogen Pharma Ltd.
Investors walked away from UroGen Pharma after an article was published by a short-seller, but clinical results appear to favor the company.
URGN earnings call for the period ending June 30, 2019.
Should you follow in their footsteps?
A major milestone gets closer with each passing day, but the stock seems to keep heading lower.
Wall Street, and most investors who follow its lead, is overlooking this online bank, pharmaceutical company, and master limited partnership. Investors who are paying attention could score outsized gains by investing ahead of the crowd.
Axsome Therapeutics, Flexion Therapeutics, and UroGen Pharma gave investors reasons for excitement.
URGN earnings call for the period ending .
This Canadian midstream company, Canadian winter clothing manufacturer, and Israel-based pharma company could soon be making names for themselves in the U.S.
This Israeli-based pharma company is poised to receive regulatory approval for its first product in the second half of 2019.